Almedalen 2017 logos website

 

Wisby Strands Veranda & Taverna

 

After Work Almedalen

Onsdag 5 juli 2017 kl. 17:00 – 19:00

Wisby Strands Veranda

Opticom, Adxto & Mimerex
arrangerar även i år ett gemensamt mingel för våra kunder.
Vi bjuder på rosé, tilltugg samt ett lättsamt samkväm med kollegor i branschen.
Vi kommer vid tillfället att informera om våra verksamheter.

Vi hoppas att du vill komma och ser fram emot att träffa dig!

Varmt välkommen önskar
Carl Michael Bergman, Helena Östregård, Pontus Torstensson och kollegor

Tyvärr har vi ett begränsat antal platser, så anmäl dig gärna så snart som möjligt: Anmälan
Om du får förhinder, meddela oss gärna via: almedalen@opticom.se

Vill du veta mer om vad vi på Opticom, Adxto och Mimerex arbetar med? Kontakta oss gärna eller besök våra hemsidor:

Carl Michael Bergman, VD, Opticom: carl.michael@opticom.se  Opticom Group Opticom International Research

Helena Östregård, VD, Adxto helena.ostregard@adxto.com Adxto

Pontus Torstensson, VD, Mimerex pontus.torstensson@mimerex.com Mimerex

 

Download PDF

Health Logos June 2017

We at Opticom are happy and grateful for the valuable partnerships and inspiring journey we have been part of the last 30 years!

We thank all our clients for trusting Opticom with important projects, and we also thank all of our co-workers and business partners for their hard work and commitment to Opticom.

Our roots stem from research and analysis, which has provided our clients with true customer understanding. This understanding has served as the foundation for decisions that aim at creating substantial value for our customers in Health, Forest Products and Industrial Goods. Numerous client testimonials show that research pays off.

Over the years, we have added Consulting to our offering, helping our clients to use real-world insights to improve business decision making. Research and Consulting are the two disciplines that we have built our success upon: it has been our privilege to serve an incredible list of globally leading companies.

In 2014, we added Communication as the third leg of our business, and thus today we at Opticom Group feel honoured to offer global research, consulting and communication.

Today we are very much looking forward to the next 30 years and beyond. We can assure you that we will continue to be passionate about understanding your key challenges and in finding solutions that deliver true value.

Download PDF
iStock_000007042359_Large

Francesco De Rosa, with vast experience from the international pharma industry at various prominent positions within sales, brand and business managing, gives the background to one of his first experiences with Opticom International Research: “At the time, I had taken over a very important Pfizer brand with a five-year legacy of declining market shares and I needed to get a 360 degree understanding of the decision-making process within the growth hormone therapy area” he explains and continues: “My scope was clear: bend the trend!”.

To gain this crucial understanding, Francesco turned to Opticom, a company which had previously delivered very good and useful results in projects for another pharmaceutical brand he had worked with. In the project of close co-operation that followed, Opticom conducted about 100 qualitative interviews with parents, paediatricians, and nurses to understand their different needs and reasoning within this therapy area.

The research discovered many “leaks” that delayed children’s access to treatment as well as large regional differences. Based on Opticom’s comprehensive analysis of the patient journey and treatment rationales, Francesco was able to change his company’s strategy, including a relocation of resources, better aligned to the customer landscape, as well as to improve communication around the value of treatment. In addition, the team could optimize its different support tools to physicians, nurses and parents, in order to facilitate earlier diagnose and better compliance.

Furthermore, Francesco and his colleagues came up with an improved treatment device to deal with an issue rated very important among respondents in the survey: Ease-of-use.

He describes the direct impact of this new, very valuable market knowledge: “Thanks to the new insights we designed a new device for the treatment of growth hormones deficiencies among children in order to meet the single most important factor in the choice of treatment: Easy-of-use of the device. This resulted in a patent available in more than 100 countries worldwide”.

As a result of the new strategy, the brand soon turned decline into growth and has been continuing this positive development ever since.

According to Francesco, the generation of updated customer insights is key to their business. Understanding both traditional and non-traditional stakeholders, their needs, as well as the patient journey and the decision-making process is fundamental in forming a successful business strategy.

In these situations you need a consulting company with a strong focus on quality, and with a thorough process for both research as well as analysis that delivers real and actionable results. That is where Opticom comes in as a very valuable partner with the staff’s vast knowledge and experience of the pharma industry:  “They are methodical in their understanding of customer needs and in making sure that the setup of the project, from the very start to result implementation, is consistent and with a great focus on details and delivery” says Francesco, who would definitely engage Opticom again to gain strategic insights and/or to facilitate optimized communication.

Download PDF

Capture

There are many people who have been part of Opticom’s history and have been valuable in contributing to our success. Our roots stem from research and analysis, which has provided our clients with true customer knowledge. This knowledge has served as the foundation for decisions that aim at creating bottom line value for our customers across the industry. Numerous client testimonials has shown that research pays off. Over the years, we have added consulting to our offering, helping our clients to reach insights that allow even better decision making. These are the two disciplines that we have built our success upon, and it has allowed us to work with an incredible list of globally leading companies. It has been our privilege to serve all these companies on a long-term basis.

We added communication as the third leg in our business in 2014, and thus today the Opticom Group offers global research, consulting and communication to all of our clients.

Our mission is to help our customers create value by transforming data and knowledge into strategic advice and efficient communication. We are a truly global company, covering over 30 nationalities active on 6 continents in more than 100 countries. Since our foundation in 1987 we have undertaken hundreds of international assignments across the world.

We thank all our clients for trusting Opticom with your important projects, and we also thank all of our co-workers and business partners for their hard work and commitment to Opticom.

Finally, we are very much looking forward to the next 30 years and beyond. We can also assure you that we will continue to be passionate about understanding your key challenges and in finding solutions that deliver true value and ROI.

Download PDF

Eye for pharma pic

Opticom took the opportunity to hear and discuss What’s cooking in Pharma, at the annual Eye for Pharma’s Barcelona Conference 2017.

Buzz words such as patient empowerment, digital services, multi-stakeholder collaboration, and customer engagement confirm that the industry is clearly widening its “customer focus” to include a stronger patient centricity and closer stakeholder collaboration as well as a broader definition of offering value through innovative services.

Opticom will continue to help health companies succeed in their healthcare ecosystem. Do contact us if you would like to talk, brainstorm, and plan your next steps towards improved value propositions!

Some interesting quotes caught at Eye for Pharma Barcelona 2017:

“Technology forces us forward: pharma on its own will cause an evolution, by partnering with external partners, we will create a revolution.” (Panel discussion)

On Patient value: “We need to get patients to be proud of us – Pharma – proud of what we have achieved. We should do a better job to convince them.” (Panel discussion)

Bottom line: regardless of the value offered: “Never surprise us (patients) with any side effect!” (Ian Talmage, Senior Advisor, Bayer)

“Pharma’s role: Helping people to get better at getting better.” (Panel discussion)

“What is the most advanced pharma company when it comes to digitalization? Not just one company, but we can see indications that they are often the smaller, midsize companies, from the Nordics or Belgium.” (Dr. Frank Kumli, Executive Director, Life Sciences, EY)

Download PDF